pcDNA3-Flag-IDH1-R132H Citations (4)

Originally described in: Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.
Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, Yu W, Li Z, Gong L, Peng Y, Ding J, Lei Q, Guan KL, Xiong Y Science. 2009 Apr 10;324(5924):261-5. doi: 10.1126/science.1170944. PubMed Journal

---

Articles Citing pcDNA3-Flag-IDH1-R132H

Articles
Butyrate Inhibits Indices of Colorectal Carcinogenesis via Enhancing alpha-Ketoglutarate-Dependent DNA Demethylation of Mismatch Repair Genes. Sun X, Zhu MJ. Mol Nutr Food Res. 2018 May;62(10):e1700932. doi: 10.1002/mnfr.201700932. Epub 2018 Apr 26. PubMed
Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutants. Avellaneda Matteo D, Wells GA, Luna LA, Grunseth AJ, Zagnitko O, Scott DA, Hoang A, Luthra A, Swairjo MA, Schiffer JM, Sohl CD. Biochem J. 2018 Oct 22;475(20):3221-3238. doi: 10.1042/BCJ20180424. PubMed
Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma. Fukunaga T, Fujita Y, Kishima H, Yamashita T. PLoS One. 2018 Nov 2;13(11):e0206552. doi: 10.1371/journal.pone.0206552. eCollection 2018. PubMed
Proteomic and phosphoproteomic landscapes of acute myeloid leukemia. Kramer MH, Zhang Q, Sprung R, Day RB, Erdmann-Gilmore P, Li Y, Xu Z, Helton NM, George DR, Mi Y, Westervelt P, Payton JE, Ramakrishnan SM, Miller CA, Link DC, DiPersio JF, Walter MJ, Townsend RR, Ley TJ. Blood. 2022 Sep 29;140(13):1533-1548. doi: 10.1182/blood.2022016033. PubMed

If you have published an article using this material, please email us at to have your article added to this page.